127 Results for "

cyclin-dependent kinase inhibitor

" in MedChemExpress (MCE) Product Catalog:
Products (127)

127 Results for "cyclin-dependent kinase inhibitor" in MCE Product Catalog:

41
41 Publications Verification
Cat. No.: HY-12214A
CAS No.: 1263373-43-8
Purity:  99.60%
Target:  

CDK Apoptosis

Research Areas:  

Cancer

NVP-2 is a potent and selective ATP-competitive cyclin dependent kinase 9 (CDK9) probe, inhibits CDK9/CycT activity with an IC50 of 0.514 nM. NVP-2 displays inhibitory effcts on CDK1/CycB, CDK2/CycA and CDK16/CycY kinases with IC50 values of 0.584 μM, 0.706 μM, and 0.605 μM, respectively. NVP-2 induces cell apoptosis.
loading...
    loading...
14
14 Cited Publications
Cat. No.: HY-12467
CAS No.: 1338545-07-5
Purity:  99.74%
Target:  

TOPK CDK Apoptosis

Research Areas:  

Cancer

OTS964 hydrochloride is an orally active, high affinity and selective TOPK (T-lymphokine-activated killer cell-originated protein kinase) inhibitor with an IC50 of 28 nM . OTS964 hydrochloride is also a potent inhibitor of the cyclin-dependent kinase CDK11, which binds to CDK11B with a Kd of 40 nM .
loading...
    loading...
7
7 Cited Publications
Cat. No.: HY-16462
CAS No.: 1263369-28-3
Target:  

CDK

Research Areas:  

Cancer

CDK9-IN-2 is a special cyclin-dependent kinase 9 (CDK9) inhibitor, extracted from patent WO/2012131594A1, compound CDKI(8), has an IC50 of 5 nM and 7 nM in H929 multiple myeloma(MM) cell line (72 hours) and A2058 skin cell line (72 hours), respectively.
loading...
    loading...
7
7 Cited Publications
Cat. No.: HY-11009
CAS No.: 164658-13-3
Purity:  98.90%
Target:  

CDK PKC

Research Areas:  

Cancer

CGP60474, a highly potent anti-endotoxemic agent, is a potent cyclin-dependent kinase (CDK) inhibitor (IC50 values are 26, 3, 4, 216, 10, 200 and 13 nM for CDK1/B, CDK2/E, CDK2/A, CDK4/D, CDK5/p25, CDK7/H and CDK9/T, respectively). CGP60474 is a selective and ATP-competitive PKC inhibitor .
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-114177
CAS No.: 2185857-97-8
Purity:  99.91%
Synonyms: PF-06873600
Target:  

CDK

Research Areas:  

Cancer

PF-06873600 is a selective and orally bioavailable inhibitor of cyclin-dependent kinase (CDK), with Ki values of 0.09 nM, 0.13 nM and 0.16 nM for CDK2, CDK4 and CDK6, respectively. PF-06873600 has potential antineoplastic activity .
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-137432
CAS No.: 1983983-41-0
Purity:  99.72%
Synonyms: BEY1107
Target:  

CDK Apoptosis

Research Areas:  

Cancer

Avotaciclib (BEY1107) is an orally active cyclin-dependent kinase 1 (CDK1) inhibitor. Avotaciclib can inhibit the proliferation and induce apoptosis of tumor cells. Avotaciclib can be used in the research of cancer such as pancreatic cancer and lung cancer .
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-137432A
CAS No.: 1983984-01-5
Purity:  99.60%
Synonyms: BEY1107 trihydrochloride
Target:  

CDK Apoptosis

Research Areas:  

Cancer

Avotaciclib (BEY1107) trihydrochloride is an orally active cyclin-dependent kinase 1 (CDK1) inhibitor. Avotaciclib trihydrochloride can inhibit the proliferation and induce apoptosis of tumor cells. Avotaciclib trihydrochloride can be used in the research of cancer such as pancreatic cancer and lung cancer .
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-137432B
Purity:  99.75%
Synonyms: BEY1107 hydrochloride
Target:  

CDK Apoptosis

Research Areas:  

Cancer

Avotaciclib (BEY1107) hydrochloride is an orally active cyclin-dependent kinase 1 (CDK1) inhibitor. Avotaciclib hydrochloride can inhibit the proliferation and induce apoptosis of tumor cells. Avotaciclib hydrochloride can be used in the research of cancer such as pancreatic cancer and lung cancer .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-16559
CAS No.: 920113-03-7
Synonyms: P276-00
Target:  

CDK Apoptosis

Research Areas:  

Cancer

Riviciclib hydrochloride (P276-00) is a potent cyclin-dependent kinase (CDK) inhibitor, which inhibits CDK9-cyclinT1, CDK4-cyclin D1, and CDK1-cyclinB with IC50s of 20 nM, 63 nM, and 79 nM, respectively . Riviciclib hydrochloride (P276-00) shows antitumor activity on cisplatin-resistant cells .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-P80774A
Synonyms: CDKN1A; CAP20; CDKN1; CIP1; MDA6; PIC1; SDI1; WAF1; cyclin-dependent kinase inhibitor 1; CDK-interacting protein 1; Melanoma differentiation-associated protein 6; MDA-6; p21

Host:  

Rabbit

Application:  

WB, ICC/IF

Reactivity:  

Human, Mouse, Rat

loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-15275
CAS No.: 582315-72-8
Purity:  99.59%
BMS-265246 is a potent and selective cyclin-dependent kinase CDK1 and CDK2 inhibitor, with IC50 values of 6 and 9 nM, respectively. BMS-265246 inhibits CHI3L1 (chitinase 3-like-1) stimulation of ACE2 (angiotensin converting enzyme 2) and SPP (viral spike protein priming proteases). BMS-265246 can be used for ovarian cancer and COVID-19 research .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-108136A
CAS No.: 145317-11-9
Purity:  98.90%
Synonyms: BIM-X hydrochloride; Ro31-8425 hydrochloride
Target:  

PKC CDK

Bisindolylmaleimide X hydrochloride(Ro 31-8425 hydrochloride, BIM-X hydrochloride) is a cell-penetrating PKC inhibitor. Bisindolylmaleimide X hydrochloride is a potent cyclin-dependent kinase 2 (CDK2) antagonist with an IC50 of 200 nM. Bisindolylmaleimide X hydrochloride inhibits the proliferation of CD4 T cells in vitro. Bisindolylmaleimide X hydrochloride inhibits eNOS-Ser1177 phosphorylation in human embryonic vein endothelial cells. Bisindolylmaleimide X hydrochloride can be used for research on the immune system and cardiovascular diseases .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-13914
CAS No.: 1223498-69-8
Purity:  98.09%
Synonyms: BAY 1000394
Target:  

CDK

Research Areas:  

Cancer

Roniciclib is an orally bioavailable pan-cyclin dependent kinase (CDK) inhibitor, with IC50s of 5-25 nM for CDK1, CDK2, CDK3, CDK4, CDK7 and CDK9.
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-141687
CAS No.: 22242-89-3
Purity:  99.97%
Target:  

CDK Apoptosis

Research Areas:  

Cancer

NSC 107512 is a potent inhibitor of cyclin-dependent kinase 9 (CDK9). NSC 107512 is a class of sangivamycin-like molecules (SLM). NSC 107512 inhibits growth and induces apoptosis of multiple myeloma tumors .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-121035
CAS No.: 916440-85-2
Purity:  99.20%
Synonyms: 7-Bromoindirubin-3-Oxime
Target:  

CDK GSK-3

Research Areas:  

Neurological Disease

7BIO (7-Bromoindirubin-3-Oxime) is the derivate of indirubin. 7BIO (7-Bromoindirubin-3-Oxime) has inhibitory effects against cyclin-dependent kinase-5 (CDK5) and glycogen synthase kinase-3β (GSK3β). 7BIO (7-Bromoindirubin-3-Oxime) inhibits Aβ oligomer-induced neuroinflammation, synaptic impairments, tau hyper-phosphorylation, activation of astrocytes and microglia, and attenuates Aβ oligomer-induced cognitive impairments in mice [1].
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-P80256
Synonyms: KIP1, p27, CDKN1B, cyclin-dependent kinase inhibitor 1B, cyclin-dependent kinase inhibitor p27, p27Kip1

Host:  

Rabbit

Application:  

WB, ICC/IF, IHC-P, FC, IP

Reactivity:  

Human, Mouse, Rat

loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-P86438
Synonyms: cyclin-dependent kinase inhibitor 2A, isoforms 1/2/3; cyclin-dependent kinase 4 inhibitor A; CDK4I; Multiple tumor suppressor 1; MTS-1; p16-INK4a; p16-INK4; p16INK4A; p16;

Host:  

Rabbit

Application:  

WB, ICC/IF, IP, ELISA

Reactivity:  

Human, Mouse, Rat

loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-P86368
Synonyms: cyclin-dependent kinase inhibitor 1 ; CDK-interacting protein 1; Melanoma differentiation-associated protein 6; MDA-6; p21;

Host:  

Rabbit

Application:  

WB, IHC-P, ICC/IF, IP, ELISA

Reactivity:  

Mouse, Rat

loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-P80773
Synonyms: CDKN1A; CAP20; CDKN1; CIP1; MDA6; PIC1; SDI1; WAF1; cyclin-dependent kinase inhibitor 1; CDK-interacting protein 1; Melanoma differentiation-associated protein 6; MDA-6; p21

Host:  

Rabbit

Application:  

WB

Reactivity:  

Human, Mouse

loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-P80615
Synonyms: CDK4 inhibitor p16 INK4 antibody; CDK4I antibody; CDKN2 antibody; CDKN2A antibody; Cell cycle negative regulator beta antibody; CMM2 antibody; cyclin dependent kinase 4 inhibitor A antibody; cyclin dependent kinase inhibitor 2A (melanoma p16 inhibits CDK4) antibody; cyclin dependent kinase inhibitor 2A antibody; cyclin dependent kinase inhibitor 2A isoform 4 antibody; cyclin dependent kinase inhibitor 2A isoforms 1/2/3 antibody; cyclin dependent kinase inhibitor p16 antibody; INK4 antibody; INK4A antibody; MLM antibody; MTS1 antibody; Multiple tumor suppressor 1 antibody; p14 antibody; p16 antibody; P16INK4 antibody; p16INK4a antibody; p19 antibody; p19Arf antibody; TP16 antibody;

Host:  

Rabbit

Application:  

WB, IP

Reactivity:  

Human, Mouse

loading...
    loading...